Literature DB >> 29240565

Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease.

Ayman Alsebaey1, Mostafa Elhelbawy, Imam Waked.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) is a global health problem that is complicated by liver fibrosis and insulin resistance (IR). AIM: The aim of this study was to validate neutrophils-to-lymphocytes ratio (NLR) and platelets-to-lymphocytes ratio (PLR) as indirect biomarkers of liver fibrosis and IR in HCV patients. PATIENTS AND METHODS: One hundred and fifty patients were enrolled. Physical examination, BMI, liver function tests, serum creatinine, complete blood count, serum HCV RNA count by PCR, and abdominal ultrasonography were performed. Transient elastography measurement using FibroScan was performed. Patients were classified into those with mild fibrosis (F1-F3) and significant fibrosis (F4). IR was defined as homeostasis model assessment of IR more than 2. NLR and PLR were calculated.
RESULTS: The average age of the patients was 47.21±10.51 years, mainly men (n=119; 79.3%), and 87.3% (n=131) had IR and 44.7% (n=67) had significant fibrosis. PLR was lower in patients with IR (74.95±37.90 vs. 94.71±31.45; P=0.032) unlike the NLR, which was comparable (P>0.05). Patients with significant fibrosis had lower PLR (66.43±39.38 vs. 86.35±33.85; P=0.001) unlike NLR (P>0.05). PLR (cutoff≥77.47) had 78.9% sensitivity, 60.3% specificity, 22.4% positive predictive value, and 95.2% negative predictive value for non-IR (P=0.008). At a cutoff of at least 63.71, PLR had 73.5% sensitivity, 61.2% specificity, 70.1% positive predictive value, and 65.1% negative predictive value for nonsignificant fibrosis (P=0.001). Age and PLR (odds ratio=0.99; 95% confidence interval=0.976-0.999) were predictors of IR, whereas age, total bilirubin, serum albumin, liver stiffness, and PLR (odds ratio=0.98; 95% confidence interval=0.974-0.994) were predictors of significant fibrosis.
CONCLUSION: PLR is useful in distinguishing the patients with significant fibrosis or IR unlike NLR.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29240565     DOI: 10.1097/MEG.0000000000001013

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients.

Authors:  Xiaoling Yuan; Sheng-Zhong Duan; Junying Cao; Nan Gao; Jie Xu; Lanjing Zhang
Journal:  Eur J Gastroenterol Hepatol       Date:  2019-11       Impact factor: 2.566

2.  Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales.

Authors:  Agata Michalak; Halina Cichoż-Lach; Małgorzata Guz; Joanna Kozicka; Marek Cybulski; Witold Jeleniewicz; Andrzej Stepulak
Journal:  World J Gastroenterol       Date:  2020-12-21       Impact factor: 5.742

3.  Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and HIV/HCV Coinfection.

Authors:  Jennifer S Hanberg; Matthew S Freiberg; Matthew B Goetz; Maria C Rodriguez-Barradas; Cynthia Gibert; Kris Ann Oursler; Amy C Justice; Janet P Tate
Journal:  Open Forum Infect Dis       Date:  2019-07-26       Impact factor: 3.835

4.  The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals.

Authors:  Hanan Mahmoud Fayed; Hasan Sedeek Mahmoud; Abdallah Elaiw Mohamed Ali
Journal:  Clin Exp Gastroenterol       Date:  2020-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.